Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multi-Center Randomized, Double-Blind, Placebo-Controlled Trial of the Ex Vivo Treatment With CGT003 of Coronary Vein Grafts in Patients Undergoing Coronary Artery Bypass Graft Procedures

NCT00042081 is registered in ClinicalTrials.gov with Anesiva, Inc. as lead sponsor.

NCT NCT00042081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00042081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multi-Center Randomized, Double-Blind, Placebo-Controlled Trial of the Ex Vivo Treatment With CGT003 of Coronary Vein Grafts in Patients Undergoing Coronary Artery Bypass Graft Procedures
Lead sponsor
Anesiva, Inc.
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2002
Completion date
February 28, 2005
Enrollment
3,000
Sites
154

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease